Nimrata Hunt - 05 Aug 2021 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Executive Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Nimrata Hunt
Issuer symbol
IDXX
Transactions as of
05 Aug 2021
Net transactions value
-$304,024
Form type
4
Filing time
09 Aug 2021, 17:00:59 UTC
Next filing
12 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $1,832 +27 +0.33% $67.85* 8,133 05 Aug 2021 Direct F1
transaction IDXX Common Stock Options Exercise $72,358 +511 +6.3% $141.60 8,644 05 Aug 2021 Direct
transaction IDXX Common Stock Sale $378,214 -538 -6.2% $703.00 8,106 05 Aug 2021 Direct
holding IDXX Common Stock 160 05 Aug 2021 jointly with spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise -27 -100% 0 05 Aug 2021 Common Stock 27 $67.85 Direct F2, F4
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise -511 -30% 1,218 05 Aug 2021 Common Stock 511 $141.60 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 23.2845 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021 and June 30, 2021.
F2 Grant of option to buy 1,940 shares of Issuer common stock that vested in five annual installments beginning on February 14, 2017.
F3 Grant of option to buy 3,579 shares of Issuer common stock that vest in five annual installments beginning on February 14, 2018.
F4 Not applicable.